Skip to content

A comparative study between Dexmedetomidine and Esmolol in keeping heart rate and blood pressure stable during gall bladder surgery using laparoscopic method under general anesthesia.

A comparative evaluation between Dexmedetomidine and Esmolol for hemodynamic responses to pneumoperitoneum during laparoscopic cholecystectomy under general anesthesia in a tertiary care hospital in Sikkim- A double blinded randomized controlled study. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093471
Enrollment
92
Registered
2025-08-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K808- Other cholelithiasis

Interventions

Intervention1: A comparative evaluation between Dexmedetomidine and Esmolol for hemodynamic responses to pneumoperitoneum during laparoscopic cholecystectomy under general anesthesia.: Once incision i

Sponsors

Sikkim Manipal Institute of Medical Science
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1 & ASA 2

Exclusion criteria

Exclusion criteria: Refusal to participate ASA 3 & ASA 4

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of two study drugs, Dexmedetomidine and Esmolol in attenuating hemodynamic parameters (heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure and oxygen saturation) during pneumoperitoneum for patients undergoing laparoscopic cholecystectomy under general anesthesia.Timepoint: At the time of giving study drug then initiation of pneumoperitoneum and every 3 minutes after the pneumoperitoneum is established and for the first 15 minutes, then every 15 minutes for the first hour and every 30 minutes for the next 2 hours or until the pneumoperitoneum ends.

Secondary

MeasureTime frame
Using Dexmedetomidine will reduce the chances of using any additional analgesic use.Timepoint: During initiation of penumoperitoneum,every 3 minutes after the pneumoperitoneum is established and for the first 15 minutes, then every 15 minutes for the first hour and every 30 minutes for the next 2 hours or until the pneumoperitoneum ends.

Countries

India

Contacts

Public ContactDr Awantika Rai

Sikkim Manipal Institute of Medical Science

meyong.b@smims.edu.in9614389839

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026